Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
Go back to Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 13.49 +0.04 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.45 | 52 Week High | $19.40 | |||
| Open | $13.48 | 52 Week Low | $12.50 | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $13.45 | EPS | $0.00 | |||
| Volume | 103,600 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.15 -0.06 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.24 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 14,401,814 | |||||
